Related Experiment Video
Updated: Jul 6, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
The molecular mechanism of polysaccharides in combating major depressive disorder: A comprehensive review
Hongwei Kong1, Tianren Xu1, Shengguang Wang2
1College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Abstract:
Major depressive disorder (MDD) is a complex psychiatric condition with diverse etiological factors. Typical pathological features include decreased cerebral cortex, subcortical structures, and grey matter volumes, as well as monoamine transmitter dysregulation. Although medications exist to treat MDD, unmet needs persist due to limited efficacy, induced side effects, and relapse upon drug withdrawal. Polysaccharides offer promising new therapies for MDD, demonstrating antidepressant effects with minimal side effects and multiple targets. These include neurotransmitter, neurotrophin, neuroinflammation, hypothalamic-pituitary-adrenal axis, mitochondrial function, oxidative stress, and intestinal flora regulation. This review explores the latest advancements in understanding the pharmacological actions and mechanisms of polysaccharides in treating major depression. We discuss the impact of polysaccharides' diverse structures and properties on their pharmacological actions, aiming to inspire new research directions and facilitate the discovery of novel anti-depressive drugs.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview
G-protein Coupled Receptors
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

